The current COVID-19 pandemic has highlighted the importance of addressing non-communicable diseases as the association between the two has created a true health crisis.
The urgency of the current pandemic has increased as we discovered how two among the most widespread diseases in the world – cardiovascular disease and obesity – are risk factors for COVID-19 and increase The current COVID-19 pandemic has highlighted the importance of addressing non-communicable diseases as the association between the two has created a true health crisisits severity. As new data is currently being collected and analysed we will gather a group of experts in these topics to discuss the links between these three diseases and understand how patients are affected by the current pandemic and how can we overcome the most common obstacles.
Date and time
- Date: 8th October 2020
- Time: 13:00-14:00 BST
- Enhance understanding of how COVID-19 is associated with both obesity and CVD
- Learn how the current pandemic has impacted treatment of patients with CVD and obesity
- Discuss case studies to gain deep and practical understanding of the links between COVID-19, CVD, and obesity
13:00-13:05 Welcome and introductions (Ada Cuevas (Chair), and Johanna Ralston)
- House keeping
- WOF/WHF Collaboration
13:05-13:15 An introduction to obesity and CVD (Wael Almahmeed)
13:15-13:25 Clinical insights: How can obesity/CVD co-morbidity exacerbate COVID-19 Complications? (Rachel Batterham)
13:25-13:30 Patient case study: Perspectives on treatment of obesity/CVD during the COVID-19 pandemic (TBC)
13:30-13:55 Panel Discussion
13:55-14:00 Final remarks from chair (Ada Cuevas, Chair)
Medical Director, Center for Advanced Metabolic Medicine and Nutrition (CAMMYN), Chile
CEO, World Obesity Federation
Director, Obesity UK
Professor of Obesity, Diabetes & Endocrinology, University College London, UK.
Staff Physician, Cardiology, Heart & Vascular Institute, Clevelend Clinic, Abu Dhabi.